glp-1 compounding fda Compounding: When Innovation May Mean Liability 🚨 FDA UPDATE — April

Like everyone has to get attention somehow if they want to make it in this world

The heightened occurrences of nausea and vomiting incidents found in the Wegovy trial align with the theory that semaglutide causes an increased risk of gastroparesis, since Wegovy is more than double the dose at 2.4mg compared to Ozempics 1mg dose

Weve run into shortages time and again, but if we had small molecules, can you imagine the access

Discussing all available avenues with a specialist ensures you can make an informed decision that feels right for you

Ultrastructural analysis revealed that the mitochondrial ridge was reduced or absent and that rupture of the outer mitochondrial membrane (OMM) occurred in the Erastin-treated group and sh-GPX4 group(Fig